TrialBioMed research international2022

Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.

Chenyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.